Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells, or angiogenesis
- Application ID: EP14176946
- Status: █ EXAMINATION IN PROGRESS
This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Boehringer Ingelheim GmbH is specialized in A61. Boehringer Ingelheim GmbH is specialised in A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.